PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
HPS (30-60 mg/kg) attenuated renal inflammatory infiltration and fibrosis in db/db mice [PMID:37771649]
HPS prolonged lifespan and ameliorated intestinal homeostasis, sleep disturbances, and beta-amyloid induced Alzheimer's symptoms in Drosophila melanogaster [PMID:37105250]
Purified HPS3 showed significant hypoglycemic effects in alloxan-induced diabetic mice, increasing plasma insulin and hepatic glycogen [PMID:20130740]
HPS (400 mg/kg) demonstrated anti-inflammatory effects in a rat model [PMID:41572999]
Purified HPS3d upregulated alkaline phosphatase activity and expression of Runx-2 and Osterix in osteoblasts [PMID:25037407]
Evidence summary
PubMed sources
- 1.PMID: 41523595 (2025) — Study on the structure of root nodules of Hedysarum polybotrys Hand.-Mazz. and the isolation and identification of rhizobia. · Plant biotechnology (Tokyo, Japan)
- 2.PMID: 37771649 (2023) — Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway. · Experimental and therapeutic medicine
- 3.PMID: 34712819 (2021) — Characterization of the complete chloroplast genome of Hedysarum polybotrys var. alaschanicum (Fabaceae) and its phylogeny. · Mitochondrial DNA. Part B, Resources
- 4.PMID: 37105250 (2023) — The antioxidant effects of hedysarum polybotrys polysaccharide in extending lifespan and ameliorating aging-related diseases in Drosophila melanogaster. · International journal of biological macromolecules
- 5.PMID: 17701565